Literature DB >> 12654346

Attenuation of N-methyl-D-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers.

C D Bown1, J F Wang, L T Young.   

Abstract

Recent post-mortem and brain imaging studies suggest that decreased neuronal and glial densities may account for cell loss in vulnerable brain regions such as the hippocampus and the frontal cortex in patients with bipolar disorder. Investigations into the mechanisms of action of mood stabilizers suggest that these drugs may regulate the expression of neuroprotective genes and protect against excitotoxicity. In this study, we characterized the ultrastructural appearance of rat hippocampal neurons pretreated with mood stabilizers and then exposed to the glutamate receptor agonist N-methyl-D-aspartate. Using transmission electron microscopy we found that rat hippocampal neurons exposed to 0.5 mM N-methyl-D-aspartate for 10 min produced more cytoplasmic vacuolization than in control neurons. Chronic treatment with mood stabilizers, lithium, valproate or carbamazepine for 7 days at therapeutically relevant concentrations fully attenuated N-methyl-D-aspartate-mediated cytoplasmic vacuolization. These results suggest that inhibition of neurotoxicity may be involved in the action of mood stabilizers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654346     DOI: 10.1016/s0306-4522(02)00743-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

1.  Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β.

Authors:  Fernando Correa; Carina Mallard; Michael Nilsson; Mats Sandberg
Journal:  Neurobiol Dis       Date:  2011-07-02       Impact factor: 5.996

Review 2.  Mood-stabilizers target the brain arachidonic acid cascade.

Authors:  Jagadeesh S Rao; Stanley I Rapoport
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339

Review 3.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 4.  Potential mechanisms of action of lithium in bipolar disorder. Current understanding.

Authors:  Gin S Malhi; Michelle Tanious; Pritha Das; Carissa M Coulston; Michael Berk
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 5.  The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.

Authors:  Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2009-06       Impact factor: 6.744

6.  Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-05-07       Impact factor: 3.996

7.  Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.

Authors:  Mireille Basselin; Nelly E Villacreses; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Biol Psychiatry       Date:  2007-07-12       Impact factor: 13.382

8.  Effects of lithium and lamotrigine on oxidative-nitrosative stress and spatial learning deficit after global cerebral ischemia.

Authors:  Ayca Ozkul; Ahmet Sair; Ali Akyol; Cigdem Yenisey; Turhan Dost; Canten Tataroglu
Journal:  Neurochem Res       Date:  2014-03-25       Impact factor: 3.996

9.  Carbamazepine Alleviates Retinal and Optic Nerve Neural Degeneration in Diabetic Mice via Nerve Growth Factor-Induced PI3K/Akt/mTOR Activation.

Authors:  Nehal M Elsherbiny; Yousra Abdel-Mottaleb; Amany Y Elkazaz; Hoda Atef; Rehab M Lashine; Amal M Youssef; Wessam Ezzat; Sabah H El-Ghaiesh; Rabie E Elshaer; Mohamed El-Shafey; Sawsan A Zaitone
Journal:  Front Neurosci       Date:  2019-11-01       Impact factor: 4.677

10.  Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers.

Authors:  Eun-Jin Kim; Dong Kun Lee; Seong-Geun Hong; Jaehee Han; Dawon Kang
Journal:  Int J Mol Sci       Date:  2017-11-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.